source
- Pfizer partners with China's Innovent Biologics on $10.5 billion deal for 12 early-stage cancer programsPfizer announced a collaboration with Innovent Biologics of China to develop a suite of cancer therapies. The agreement covers up to 12 early-stage antibody‑drug conjugates and multi‑specific anti…
- Positive data from Bristol Myers in multiple myeloma and Pfizer in lung cancer unveiled at ASCOAt the American Society of Clinical Oncology (ASCO) meeting, Bristol Myers Squibb presented early-stage results that showed a favorable response in a multiple myeloma trial. The data suggest the in…